The time has not yet come to remove your chips from the table: Kymera Therapeutics Inc (KYMR)

With 0.64 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.56 million shares. The 52-week range on KYMR shows that it touched its highest point at $53.27 and its lowest point at $29.07 during that stretch. It currently has a 1-year price target of $58.82. Beta for the stock currently stands at 2.18.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of KYMR was up-trending over the past week, with a rise of 4.91%, but this was down by -14.64% over a month. Three-month performance dropped to -29.89% while six-month performance fell -28.76%. The stock lost -21.50% in the past year, while it has lost -18.25% so far this year. A look at the trailing 12-month EPS for KYMR yields -2.97 with Next year EPS estimates of -4.03. For the next quarter, that number is -0.89. This implies an EPS growth rate of -20.69% for this year and -12.03% for next year. EPS is expected to decline by -10.79% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -26.36%.

Float and Shares Shorts:

At present, 64.89 million KYMR shares are outstanding with a float of 53.96 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for KYMR since 8 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.15372 being high and -$3.15474 being low. For KYMR, this leads to a yearly average estimate of -$2.82107. Based on analyst estimates, the high estimate for the next quarter is -$0.57 and the low estimate is -$1.07. The average estimate for the next quarter is thus -$0.9.